Charles Dumontet - Concepedia

Author

Charles Dumontet

Also Known As

Bera, Jean-Christophe, C DUMONTET, C Dumontet, C. DUMONTET, C. Dumontet, C. M. Dumontet, Cabral, F, Ch. Dumontet, Chaix, Carole, Charles Dumontet

711

Publications

30K

Citations

H-Index

206

Concepts

All Affiliations

Inserm Université Claude Bernard Lyon 1 Centre de Recherche en Cancérologie de Lyon Centre National de la Recherche Scientifique Hospices Civils de Lyon

About

Charles Dumontet is an author at Inserm specializing in medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	113	5.6K
2	Health Sciences	18	23	956
3	Natural Sciences	15	17	920
4	Engineering	8	8	316
5	Arts	1	1	14

Charles Dumontet

248

Publications

18.2K

Citations

H-Index

Page 1

	Year	Citations
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit, New England Journal of Medicine	2012	1.1K
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau, Blood	2007	899
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma Michel Attal, Jean‐Luc Harousseau, Serge Leyvraz, Blood	2006	667
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial Judith Hugh, John Hanson, Maggie C.U. Cheang, Journal of Clinical Oncology	2009	533
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed Catherine Thiéblemont, Françoise Berger, Charles Dumontet, Blood	2000	514
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma Jennifer L. Spratlin, Randeep Sangha, Darryl Glubrecht, Clinical Cancer Research	2004	425
Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. Catherine Thiéblemont, Y Bastion, F Berger, Journal of Clinical Oncology	1997	384
Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab <i>In Vitro</i> and in Xenograft Models Sylvia Herter, Frank Herting, Olaf Mundigl, Molecular Cancer Therapeutics Xenograft ModelsImmunologyImmune RegulationCell DeathImmunologic Mechanism	2013	352
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults Olivier Héquet, Q.H. Le, Isabelle Moullet, Journal of Clinical Oncology	2004	334
SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies Jutta Deckert, Marie-Cécile Wetzel, Laura M. Bartle, Clinical Cancer Research	2014	321

Page 1